I’m from Beijing, China. I obtained my undergraduate degree at Kenyon College in 2024. I study how rhabdomyosarcoma evades natural killer (NK) cell–mediated killing, with the goal of improving NK cell–based therapies. I use a multi-omics approach to uncover the molecular and epigenetic mechanisms underlying tumor immune resistance.